BioSpace News Archive

Business

Trevena to Release Second Quarter 2022 Financial Results on August 11, 2022 Company to host a Conference Call & Webcast at 8:00 a.m. ET

Trevena, Inc. today announced that it will release its financial results for the second quarter ended June 30, 2022, prior to the market open on Thursday, August 11, 2022.

August 8, 2022
·
1 min read
Business

Viatris Reports Strong Second Quarter 2022 Results

Viatris Inc. (NASDAQ: VTRS) today reported strong results for the second quarter of 2022 and provided an update to its full year 2022 financial guidance.

August 8, 2022
·
34 min read
Business

Initial Analysis of Tumor Profiling From a Prospective Study by Foundation Medicine

Foundation Medicine, Inc., Flatiron Health, and Genentech, members of the Roche Group, in partnership with a network of community oncology practices, today announced new research in the Journal of Thoracic Oncology Clinical and Research Reports.

August 8, 2022
·
7 min read
Bio NC

150 Orphan Drug Indication Approvals Trusted to Calyx IRT

Calyx, today announced it has achieved a milestone in supporting the clinical development of approved treatments for rare diseases.

August 8, 2022
·
2 min read
Viscosupplementation Market: Rise in Prevalence of Osteoarthritis among Geriatric Population to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Viscosupplement drugs can be administered using single injection, three injections, and five injections.

August 8, 2022
·
6 min read
Medical Thought Leaders in Critical Care Aim to Advance Precision Medicine Using Biomarker-Based Approaches

The diagnostics company SphingoTec GmbH, announces that, during the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.

August 8, 2022
·
8 min read
Drug Development

PNAS Published Preclinical Results of Harbour BioMed’s Next-Generation Fully Human Heavy-chain Antibody Porustobart

Harbour BioMed announced that the preclinical results of porustobart, a next-generation fully human heavy-chain antibody with a Treg depletion mechanism, were published in the Proceedings of the National Academy of Sciences.

August 8, 2022
·
3 min read
Business

BioNTech Announces Second Quarter 2022 Financial Results and Corporate Update

BioNTech SE reported financial results for the three and six months ended June 30, 2022 and provided an update on its corporate progress.

August 8, 2022
·
44 min read
Business

ViewRay Selects Denver for Headquarters

ViewRay, Inc., a medical device company that designs, manufactures, and markets the MRIdian® radiation therapy system, announced that it is moving its headquarters to Denver, Colorado as it continues to attract top-tier talent from the state’s growing medical technology sector.

August 8, 2022
·
6 min read
Business

TCR² Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer patients suffering from solid tumors, announced financial results for the second quarter ended June 30, 2022 and provided a corporate update.

August 8, 2022
·
11 min read